BH2 and Longevity: What the 2026 Nature Cold Study Actually Found
Mild cold made worms live longer, and scientists finally found a big part of why. A study published in Nature on October 21, 2026 shows that cold temperatures trigger muscle tissue to produce a metabolite called dihydrobiopterin, or BH2. That molecule travels through the body, keeps proteins from clumping as the animal ages, and extended the worms’ lifespan by roughly 15 percent. In human cells grown in a dish, BH2 reduced the protein clumps behind Huntington’s disease and ALS.
This is one of the most concrete cold-longevity mechanisms anyone has published, and it arrived with a rare thing in longevity science: a clear, testable chain from temperature to molecule to outcome. Here is what the researchers actually did, what they measured, and what it does not mean.
What Is BH2, Exactly?
BH2 stands for dihydrobiopterin. It is the stable, inactive form of a helper molecule called BH4 (tetrahydrobiopterin), which several enzymes in the body need in order to do their jobs. Cells store and ship the stable BH2 form, then convert it into the active BH4 form exactly where it is needed.
BH4 itself is not new to medicine. It is already used to treat some patients with phenylketonuria, a disorder of phenylalanine metabolism. But the study’s lead investigator, Professor Dr. David Vilchez of the University of Cologne, was explicit about the boundary: BH2 and BH4 are different molecules, and the existing BH4 treatments do not establish that BH2 would be safe or effective for promoting longevity in people.
What is new is the role the study assigns to BH2: a cold-triggered, muscle-made signal that coordinates protein maintenance across the whole body.
The Experiment: 15 Degrees, 45 Molecules, One Winner
The research team, led by Hyun Ju Lee and David Vilchez at the CECAD Cologne Cluster of Excellence on Aging and Aging-associated Diseases (with the Center for Molecular Medicine Cologne and University Hospital Cologne, in collaboration with the laboratories of Thorsten Hoppe and Christian Frezza), worked with the nematode Caenorhabditis elegans, the standard model organism for aging research.
Lab worms are normally kept at 68 degrees Fahrenheit (20 degrees Celsius), and 77 degrees Fahrenheit (25 degrees Celsius) counts as warm for them. The researchers moved adult worms to 59 degrees Fahrenheit (15 degrees Celsius) and watched them live considerably longer: about five extra days on average, roughly a 15 percent lifespan extension.
Then came the chemistry. The team compared the metabolite profiles of adult worms after five days at each of the three temperatures. Forty-five small molecules rose in the cold worms, and the result held across two separate experiments. BH2 had one of the biggest increases. Several of the other rising molecules were related to it, including the amino acids phenylalanine and tyrosine.
BH2 levels began rising on the first day of adulthood and stayed elevated through at least day 10. That early, sustained rise is what made the team pick this molecule to investigate further.
The enzyme that starts BH2 production is called CAT-4 (the worm counterpart of human GCH1), and it was among the proteins the cold raised most. When the team reduced CAT-4 in adult worms, most of the cold’s extra lifespan disappeared. Worms at normal or warm temperature with the same reduction lived as long as ever, which showed the enzyme specifically carries the cold benefit rather than general health.
How Does Muscle Become a “Central Factory” for Longevity?
The most striking finding is where the signal comes from. At normal temperature, the CAT-4 enzyme was barely present in muscle. In the cold, muscle cells made large amounts of it. The researchers call muscle a “central factory” for BH2: it synthesizes the metabolite, stores it, and releases it to the rest of the body.
The tissue experiments were precise. Reducing CAT-4 in muscle alone shortened the cold worms’ lives. Reducing it in the gut, the nerves, the skin, or the reproductive cells changed nothing. Each of those lifespan tests followed 96 worms per group, so the muscle-specific result is not a sampling fluke.
Then the signal travels. A second enzyme, DHFR-1, converts BH2 into its active BH4 form, and the cold worms needed that conversion in their nerves, gut, and reproductive cells, not in muscle. They also depended on transporter proteins that carry BH2 into cells. The picture is clean: muscle makes the molecule, distant tissues take it in and activate it.
The reach of the signal is visible in the gut. A gut protein called IFB-2 clumps together as worms age, and cold normally prevents that clumping. When the researchers reduced the BH2-making enzyme in muscle alone, the gut protein clumped anyway, even in the cold. One tissue’s chemistry was protecting another tissue’s proteins.
The team also ran the experiment in reverse. They engineered worms whose muscles made extra CAT-4 regardless of temperature, and those worms lived longer in the cold, at normal temperature, and even in the warmth. Their gut protein stayed unclumped at normal temperature, and fewer bacteria invaded their intestines in old age. Muscle-made BH2 was sufficient to reproduce cold’s benefits without the cold.
What About BH2 Supplements? The Feeding Experiments
This is where the study gets directly relevant to the supplement question, and the answer is nuanced. Adding BH2 to the worms’ food was a weaker tool, because worms absorb little of it. Worms fed BH2 lived slightly longer in the cold but no longer at normal temperature. They did keep moving like younger worms for longer, and they produced as many offspring as untreated worms, so there were healthspan signs even without the lifespan gain.
The downstream molecule worked better. BH4 serves four enzymes in the worm, and only one of them mattered for the cold effect: PAH-1, the enzyme that turns phenylalanine into tyrosine. Worms lacking that enzyme did not get the cold’s full benefit. And tyrosine itself did the job: adult worms given tyrosine lived longer both in the cold and at normal temperature, and tyrosine restored the lost lifespan in cold worms that made less BH2.
In other words, the longevity signal is not BH2 alone. It is a chain: cold raises muscle BH2, tissues convert it to BH4, BH4 feeds the PAH-1 enzyme, tyrosine production rises, and protein maintenance improves. Tyrosine is the downstream effector, and it reproduced the longevity benefit at normal temperature.
What Happened in Human Cells
The team then tried both molecules on human cells kept at body temperature, 98.6 degrees Fahrenheit (37 degrees Celsius). In kidney cells engineered to carry the mutant protein behind Huntington’s disease, three days of BH2 sharply reduced the protein’s clumping. The cells made just as much of the protein; it clumped less. That distinction matters, because it points to the protein-maintenance machinery rather than suppressed protein production.
BH2 did the same for two mutant proteins that cause inherited forms of ALS, involving TDP-43 and FUS. Tyrosine reduced the Huntington’s clumps as well. Then the researchers grew motor neurons, the nerve cells ALS destroys, from stem cells carrying a severe ALS mutation. Those neurons die faster in a dish than matched healthy neurons do, and either BH2 or tyrosine reduced the dying.
There is also a built-in caution in the cell data. When the researchers exposed the human cells to a chemical that causes oxidative stress, BH2 stopped protecting them, while tyrosine kept working. Oxidative stress appears to interfere with the conversion of BH2 into BH4, which means directly supplementing BH2 may not reproduce the pathway’s effects in every biological context. The downstream amino acid looks more robust than the upstream signal.
Two of the authors, Vilchez and Hyun Ju Lee, are named on a pending patent application covering the use of BH4, its precursors, and the molecules made from it to prevent or treat motor dysfunction. That tells you where the commercial interest sits: neurodegenerative disease, not a consumer longevity pill.
The 24-Hour Coverage Audit: How the BH2 Finding Broke
This is the original research for this article. I tracked every independent outlet that covered the study in the first 24 hours after the Nature paper published on October 21, 2026, recording what each one added. Nobody else has compiled this timeline.
The institutional release from the University of Cologne set the baseline. Then phys.org published at 11:00 AM Eastern on October 21 with the headline “Newly identified metabolic pathway helps explain how cold extends lifespan,” carrying the full institutional account including Vilchez’s quote about muscle producing and releasing BH2. MedLabPortal, the German medical press outlet, followed the same day with the DOI featured prominently and the collaboration with the Hoppe and Frezza laboratories spelled out.
Scienmag published at 9:48 PM UTC on October 21 with the paper-level detail: the full author list, the DHFR-1 and PAH-1 enzyme chain, the experimental design notes including 96 animals per lifespan condition and experiments repeated by at least two researchers. TakeToNews added the plain-language consumer numbers the same day: about five extra days of life, roughly 15 percent.
Then earth.com published at 8:42 AM UTC on October 22 with something none of the others had: a direct interview with Vilchez. That interview produced the study’s most important caveats, the patent disclosure, and the phenylketonuria context. It also produced the quote I keep coming back to: “One of the most interesting aspects of our findings is that muscle plays a role beyond its traditional functions in movement and energy metabolism. It can also act as a source of metabolic signals that communicate information about the body temperature to the rest of the organism.”
Quotable summary: Five independent outlets on two continents covered the BH2 cold-longevity paper within 24 hours of publication, one of the fastest coverage cascades I have tracked for a longevity study. The speed reflects what the paper actually delivers: a complete, named molecular chain from cold to lifespan, the rarest thing in aging research.
What This Does Not Mean
Vilchez himself drew the lines, and they are worth repeating exactly.
First, a worm result is not advice about cold exposure. He told earth.com that cold-blooded animals, including worms, fish, and frogs, depend on their surroundings to regulate body temperature, while humans maintain a relatively steady core temperature and respond to cold by generating more heat. His example: “sleeping in a cool room does not necessarily mean that our core body temperature decreases significantly.” If you read my earlier piece on whether cold plunges are actually worth it, this study does not settle that question for humans. It explains a mechanism in worms.
Second, it is far too early for a pill. The researchers’ own words: at the current state of research, developing a treatment that replicates the longevity-promoting effects of cold is still a distant prospect. Before either molecule reaches a human trial, the team has to work out doses, learn how the molecules behave in the body, and test their safety. The conditions Vilchez has in mind are age-related brain diseases like ALS and Huntington’s, not general life extension.
Third, the biology has open holes the authors acknowledge. Forty-five molecules rose in the cold worms, and the team followed one. Whether the other 44 carry signals of their own is unknown. Whether any of this works in a mammal is unknown. The experiments used adult hermaphrodite worms with synchronized populations, sample sizes were not determined through statistical power calculations, and conditions were not processed in a blinded manner. The worm results establish a causal pathway within the experimental model. Their relevance to mammalian aging, disease prevention, and human supplementation remains untested.
What I Am Watching Next
I track longevity studies the way I track cameras: the mechanism matters more than the headline. What makes this paper different from most “cold extends life” coverage is that it names every link in the chain. Cold, muscle CAT-4, BH2, DHFR-1, BH4, PAH-1, tyrosine, protein homeostasis. If any link fails in mammals, the whole chain is a worm story. If the chain holds, the interesting molecule may not be BH2 at all. It may be tyrosine, the downstream effector that worked at normal temperature, survived oxidative stress, and restored lifespan when BH2 production was crippled.
The other thread worth watching is the patent. Vilchez and Lee’s pending application on BH4, its precursors, and downstream molecules for motor dysfunction means industry money will now chase this pathway. That is how worm findings become human trials: not through supplement hype, but through a patent, a dose, and a disease. I will update this article when the first mammalian data appears. Related reading: an AI that estimates biological age from a face photo and the longevity gene study I covered earlier this month.
Frequently Asked Questions
What is BH2?
BH2, or dihydrobiopterin, is the stable, inactive form of the helper molecule BH4. A 2026 Nature study found that mild cold triggers muscle tissue to produce BH2, which travels to other tissues, gets converted to BH4, and supports the cellular machinery that keeps proteins properly folded during aging.
How much longer did the cold worms live?
Worms kept at 59 degrees Fahrenheit (15 degrees Celsius) lived about five days longer on average than worms at normal or warm temperatures, roughly a 15 percent lifespan extension. Each lifespan test followed 96 worms per condition.
Can I take BH2 as a supplement for longevity?
No responsible answer exists yet. The study authors state it is far too early for a BH2 longevity pill. BH2 is not an approved supplement, the human evidence is limited to cells in a dish, and the researchers emphasize that doses, bodily behavior, and safety all remain unstudied in people.
Does this prove cold plunges extend human life?
No. The study was conducted in worms and human cells, not people. The lead researcher explicitly cautioned that humans regulate core temperature differently from cold-blooded animals, and that sleeping in a cool room does not necessarily lower core body temperature.
What is the connection between BH2 and tyrosine?
BH2 is converted into active BH4 in distant tissues. BH4 feeds the enzyme PAH-1, which produces the amino acid tyrosine. In the study, tyrosine supplementation reproduced the longevity benefit at normal temperature and kept working under oxidative stress conditions where BH2 stopped working.
Where was the study published?
“Cold activates a BH2 metabolic network promoting longevity and proteostasis,” published in Nature on October 21, 2026, DOI 10.1038/s41586-026-11152-9, led by Hyun Ju Lee and David Vilchez at the University of Cologne’s CECAD aging research center.
